{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:47:13Z","timestamp":1793677633996,"version":"4.5.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10787-025-01767-1","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:48:05Z","timestamp":1746330485000},"page":"2537-2563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders"],"prefix":"10.1007","volume":"33","author":[{"given":"Trilochan","family":"Satapathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0445-0404","authenticated-orcid":false,"given":"Anjali","family":"Minj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,4]]},"reference":[{"issue":"7","key":"1767_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0953-6205(02)00132-2","volume":"13","author":"HC Ablij","year":"2002","unstructured":"Ablij HC, Meinders AE (2002) C-reactive protein: history and revival. Eur J Intern Med 13(7):412\u2013422","journal-title":"Eur J Intern Med"},{"issue":"8","key":"1767_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/children9081193","volume":"9","author":"C Agostinis-Sobrinho","year":"2022","unstructured":"Agostinis-Sobrinho C, Vicente SE, Norkiene S, Rauckien\u0117-Michaelsson A, Kievisien\u0117 J, Dubey VP, Razbadauskas A, Lopes L, Santos R (2022) Is the leptin\/adiponectin ratio a better diagnostic biomarker for insulin resistance than leptin or adiponectin alone in adolescents? Children 9(8):1193","journal-title":"Children"},{"key":"1767_CR3","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.ajpc.2020.100130","volume":"4","author":"A Alfaddagh","year":"2020","unstructured":"Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, Jones SR, Toth PP (2020) Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prevent Cardiol. 4:100130","journal-title":"Am J Prevent Cardiol."},{"issue":"11","key":"1767_CR4","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/1529-0131(200111)44:11<2531::AID-ART433>3.0.CO;2-J","volume":"44","author":"R Altman","year":"2001","unstructured":"Altman R, Marcussen KC (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44(11):2531\u20132538","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1767_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1055\/s-2006-947227","volume":"72","author":"HP Ammon","year":"2006","unstructured":"Ammon HP (2006) Boswellic acids in chronic inflammatory diseases. Planta Med 72(12):1100\u20131116","journal-title":"Planta Med"},{"issue":"2","key":"1767_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","volume":"59","author":"M Arici","year":"2001","unstructured":"Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59(2):407\u2013414","journal-title":"Kidney Int"},{"key":"1767_CR7","first-page":"83","volume":"1","author":"TB Azeez","year":"2021","unstructured":"Azeez TB, Lunghar J (2021) Antiinflammatory effects of turmeric (Curcuma longa) and ginger (Zingiber officinale). Inflam Nat Prod 1:83\u2013102","journal-title":"Inflam Nat Prod"},{"issue":"9","key":"1767_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fimmu.2018.00430","volume":"2","author":"L Badimon","year":"2018","unstructured":"Badimon L, Pe\u00f1a E, Arderiu G, Padr\u00f3 T, Slevin M, Vilahur G, Chiva-Blanch G (2018) C-reactive protein in atherothrombosis and angiogenesis. Front Immunol 2(9):430. https:\/\/doi.org\/10.3389\/fimmu.2018.00430","journal-title":"Front Immunol"},{"issue":"2","key":"1767_CR9","first-page":"1024","volume":"17","author":"AR B\u0103l\u0103nescu","year":"2019","unstructured":"B\u0103l\u0103nescu AR, Bojinc\u0103 VC, Bojinc\u0103 M, Donisan T, B\u0103l\u0103nescu SM (2019) Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases. Exp Ther Med 17(2):1024\u20131029","journal-title":"Exp Ther Med"},{"key":"1767_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30225","author":"T Banait","year":"2022","unstructured":"Banait T, Wanjari A, Danade V, Banait S, Jain J (2022) Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus. https:\/\/doi.org\/10.7759\/cureus.30225","journal-title":"Cureus."},{"key":"1767_CR11","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8355.4646","author":"T Bansal","year":"2014","unstructured":"Bansal T, Pandey A, Deepa D, Asthana AK (2014) C-reactive protein (CRP) and its association with periodontal disease: a brief review. J Clin Diagnos Res JCDR. https:\/\/doi.org\/10.7860\/JCDR\/2014\/8355.4646","journal-title":"J Clin Diagnos Res JCDR."},{"issue":"2","key":"1767_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nut.2010.01.015","volume":"27","author":"A Basu","year":"2011","unstructured":"Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27(2):206\u2013213","journal-title":"Nutrition"},{"issue":"9","key":"1767_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96(9):939\u2013949","journal-title":"Circ Res"},{"issue":"4","key":"1767_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1084\/jem.190.4.585","volume":"190","author":"D Bharadwaj","year":"1999","unstructured":"Bharadwaj D, Stein MP, Volzer M, Mold C, Clos TW (1999) The major receptor for C-reactive protein on leukocytes is Fc\u03b3 receptor II. J Exp Med 190(4):585\u2013590","journal-title":"J Exp Med"},{"key":"1767_CR15","first-page":"10","volume":"22","author":"I Biswas","year":"2020","unstructured":"Biswas I, Khan GA (2020) Endothelial dysfunction in cardiovascular diseases. Basic Clin Underst Microcirc 22:10","journal-title":"Basic Clin Underst Microcirc"},{"issue":"47","key":"1767_CR16","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487\u201348490","journal-title":"J Biol Chem"},{"issue":"8","key":"1767_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.CIR.0000139338.12464.5F","volume":"110","author":"P Bogaty","year":"2004","unstructured":"Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR (2004) Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 110(8):934\u2013939","journal-title":"Circulation"},{"issue":"6","key":"1767_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1039\/c2fo10288a","volume":"3","author":"SK B\u00f8hn","year":"2012","unstructured":"B\u00f8hn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food Funct 3(6):575\u2013591","journal-title":"Food Funct"},{"issue":"4","key":"1767_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.15171\/jhp.2018.33","volume":"7","author":"N Boroumand","year":"2018","unstructured":"Boroumand N, Samarghandian S, Hashemy SI (2018) Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 7(4):211\u2013219","journal-title":"J Herbmed Pharmacol"},{"issue":"6","key":"1767_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/14740338.4.6.1005","volume":"4","author":"JM Brophy","year":"2005","unstructured":"Brophy JM (2005) Celecoxib and cardiovascular risks. Expert Opin Drug Saf 4(6):1005\u20131015","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"1767_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1753-5174.2007.00002.x","volume":"1","author":"CP Cannon","year":"2008","unstructured":"Cannon CP, Chen C, Curtis SP, Viscusi J, Ahmed T, DiBattiste PM (2008) A comparison of cardiovascular biomarkers in patients treated for three months with etoricoxib, celecoxib, ibuprofen, and placebo. Arch Drug Inf 1(1):4\u201313","journal-title":"Arch Drug Inf"},{"issue":"1","key":"1767_CR22","first-page":"1","volume":"1","author":"IL Cardoso","year":"2017","unstructured":"Cardoso IL, Paulos AT (2017) C reactive protein and cardiovascular disease. Int Arch Cardiovasc Dis 1(1):1\u20131","journal-title":"Int Arch Cardiovasc Dis"},{"issue":"11","key":"1767_CR23","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3390\/molecules23112778","volume":"23","author":"M Catanzaro","year":"2018","unstructured":"Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C (2018) Immunomodulators inspired by nature: a review on curcumin and echinacea. Molecules 23(11):2778","journal-title":"Molecules"},{"issue":"11","key":"1767_CR24","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"B Chandran","year":"2012","unstructured":"Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719\u20131725","journal-title":"Phytother Res"},{"issue":"3","key":"1767_CR25","first-page":"25","volume":"9","author":"A Chattopadhyay","year":"2020","unstructured":"Chattopadhyay A (2020) The adverse effects of corticosteroids. Eur J Sports Exerc Sci 9(3):25\u201332","journal-title":"Eur J Sports Exerc Sci"},{"issue":"438","key":"1767_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cca.2014.07.039","volume":"1","author":"JY Choe","year":"2015","unstructured":"Choe JY, Kim SK (2015) Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta 1(438):29\u201334","journal-title":"Clin Chim Acta"},{"issue":"6","key":"1767_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1365-2222.2004.01970.x","volume":"34","author":"G Ciprandi","year":"2004","unstructured":"Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA (2004) Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 34(6):891\u2013896. https:\/\/doi.org\/10.1111\/j.1365-2222.2004.01970.x","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"1767_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0736-4679(99)00135-3","volume":"17","author":"B Clyne","year":"1999","unstructured":"Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17(6):1019\u20131025","journal-title":"J Emerg Med"},{"issue":"7","key":"1767_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316\u20131322","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1767_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ncprheum0562","volume":"3","author":"J Dale","year":"2007","unstructured":"Dale J, Alcorn N, Capell H, Madhok R (2007) Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Nat Clin Pract Rheumatol 3(8):450\u2013458","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1767_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","volume":"38","author":"NM Davies","year":"2000","unstructured":"Davies NM, McLachlan AJ, Day RO, Williams KM (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 38:225\u2013242","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1767_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40744-019-00189-0","volume":"7","author":"DJ DeMizio","year":"2020","unstructured":"DeMizio DJ, Geraldino-Pardilla LB (2020) Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Therapy 7(1):19\u201333","journal-title":"Rheumatol Therapy"},{"key":"1767_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1717","volume":"7","author":"PH Dessein","year":"2005","unstructured":"Dessein PH, Joffe BI, Singh S (2005) Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 7:1","journal-title":"Arthritis Res Ther"},{"key":"1767_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-020-00771-7","volume":"21","author":"KS Dixit","year":"2020","unstructured":"Dixit KS, Kumthekar PU (2020) Optimal management of corticosteroids in patients with intracranial malignancies. Curr Treat Options Oncol 21:1\u20131","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"1767_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/07853890009011772","volume":"32","author":"TW Du Clos","year":"2000","unstructured":"Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274\u2013278","journal-title":"Ann Med"},{"issue":"48","key":"1767_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-2423(09)48005-3","volume":"1","author":"CM Eklund","year":"2009","unstructured":"Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 1(48):111\u2013136","journal-title":"Adv Clin Chem"},{"issue":"10","key":"1767_CR37","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, C\u00f4t\u00e9 R, Grover SA, Fortin PR, Clarke AE, Sen\u00e9cal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331\u20132337","journal-title":"Arthritis Rheum"},{"issue":"8S","key":"1767_CR38","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8S):C7-12","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1767_CR39","first-page":"247","volume":"105","author":"LD Ferguson","year":"2021","unstructured":"Ferguson LD, Sattar N, McInnes IB (2021) Managing cardiovascular risk in patients with rheumatic disease. Medical Clinics 105(2):247\u2013262","journal-title":"Medical Clinics"},{"issue":"17","key":"1767_CR40","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1056\/NEJMp048288","volume":"351","author":"GA FitzGerald","year":"2004","unstructured":"FitzGerald GA (2004) Coxibs and cardiovascular disease. N Engl J Med 351(17):1709\u20131711","journal-title":"N Engl J Med"},{"key":"1767_CR41","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190925163827","author":"GD Flora","year":"2019","unstructured":"Flora GD, Nayak MK (2019) A brief review of cardiovascular diseases (atherosclerosis, hypertension, thrombosis and stroke), associated risk factors and current treatment regimes. Curr Pharmaceut Desn. https:\/\/doi.org\/10.2174\/1381612825666190925163827","journal-title":"Curr Pharmaceut Desn."},{"key":"1767_CR42","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S282691","author":"GE Fragoulis","year":"2021","unstructured":"Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, Kitas G D (2021) Effect of biologics on cardiovascular inflammation: mechanistic insights and risk reduction. J Inflam Res. https:\/\/doi.org\/10.2147\/JIR.S282691","journal-title":"J Inflam Res"},{"key":"1767_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd J (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:1\u20133","journal-title":"BMC Med"},{"issue":"3","key":"1767_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/np8006183","volume":"72","author":"JL Funk","year":"2009","unstructured":"Funk JL, Frye JB, Oyarzo JN, Timmermann BN (2009) Comparative effects of two gingerol-containing Zingiber officinale extracts on experimental rheumatoid arthritis. J Nat Prod 72(3):403\u2013407","journal-title":"J Nat Prod"},{"issue":"7","key":"1767_CR45","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan TJ (2010) Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 26(7):1715\u20131731","journal-title":"Curr Med Res Opin"},{"key":"1767_CR46","unstructured":"Gaziano T, Reddy KS, Paccaud F, Horton S, Chaturvedi V (2006) Cardiovascular disease. Disease control priorities in developing countries. 2nd edition"},{"issue":"3","key":"1767_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4236\/ojra.2016.63013","volume":"6","author":"B Ghosh","year":"2016","unstructured":"Ghosh B, Baidya D, Halder P, Mandal S (2016) Correlation of serum uric acid with disease activity and C-reactive protein in patients suffering from rheumatoid arthritis. Open J Rheumatol Autoimmune Dis 6(3):79\u201384","journal-title":"Open J Rheumatol Autoimmune Dis"},{"key":"1767_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-014-0435-z","volume":"16","author":"E Golia","year":"2014","unstructured":"Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, Bianchi R, Crisci M, D\u2019Acierno L, Giordano R, Di Palma G (2014) Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep 16:1\u20137","journal-title":"Curr Atheroscler Rep"},{"key":"1767_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/9780470660379.ch9","volume":"16","author":"A Gonz\u00e1lez-P\u00e9rez","year":"2010","unstructured":"Gonz\u00e1lez-P\u00e9rez A, Garc\u00eda Rodriguez LA (2010) Cardiovascular toxicities of NSAIDS: epidemiologic aspects. Cardiotox Non-Cardiovasc Drugs 16:287\u2013312","journal-title":"Cardiotox Non-Cardiovasc Drugs"},{"issue":"2","key":"1767_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/jmf.2005.8.125","volume":"8","author":"R Grzanna","year":"2005","unstructured":"Grzanna R, Lindmark L, Frondoza CG (2005) Ginger an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8(2):125\u2013132","journal-title":"J Med Food"},{"issue":"122","key":"1767_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110655","volume":"1","author":"H Guo","year":"2023","unstructured":"Guo H, Li L, Liu B, Lu P, Cao Z, Ji X, Ouyang G, Nie Z, Lyu A, Lu C (2023) Inappropriate treatment response to DMARDs: a pathway to difficult-to-treat rheumatoid arthritis. Int Immunopharmacol 1(122):110655","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1767_CR52","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00210-023-02703-2","volume":"397","author":"M Gupta","year":"2024","unstructured":"Gupta M, Rumman M, Singh B, Mahdi AA, Pandey S (2024) Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study. Naunyn Schmiedebergs Arch Pharmacol 397(3):1647\u20131658","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1767_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2471","volume":"10","author":"BH Hahn","year":"2008","unstructured":"Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 10:1\u20132","journal-title":"Arthritis Res Ther"},{"issue":"21","key":"1767_CR54","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","volume":"23","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F (2022) The role of inflammation in cardiovascular disease. Int J Mol Sci 23(21):12906","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1767_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: a review of its effects on human health. Foods 6(10):92","journal-title":"Foods"},{"key":"1767_CR56","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2012","author":"PN Hopkins","year":"2013","unstructured":"Hopkins PN (2013) Molecular biology of atherosclerosis. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00004.2012","journal-title":"Physiol Rev"},{"issue":"6","key":"1767_CR57","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/ijms23063346","volume":"23","author":"S Jebari-Benslaiman","year":"2022","unstructured":"Jebari-Benslaiman S, Galicia-Garc\u00eda U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Mart\u00edn C (2022) Pathophysiology of atherosclerosis. Int J Mol Sci 23(6):3346","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1767_CR58","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.ATV.0000206211.21895.73","volume":"26","author":"SR Ji","year":"2006","unstructured":"Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J (2006) Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 26(4):935\u2013941","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1767_CR59","first-page":"61","volume":"5","author":"J Jura","year":"2011","unstructured":"Jura J, Koj A (2011) Regulatory mechanisms controlling inflammation and synthesis of acute phase proteins. Acute Phase Proteins Regul Funct Acute Phase Proteins 5:61\u201384","journal-title":"Acute Phase Proteins Regul Funct Acute Phase Proteins"},{"issue":"4","key":"1767_CR60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1163\/156856005774415565","volume":"13","author":"WF Kean","year":"2005","unstructured":"Kean WF, Buchanan WW (2005) The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacology 13(4):343\u2013370","journal-title":"Inflammopharmacology"},{"issue":"1\u20132","key":"1767_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2008.07.008","volume":"120","author":"EY Kim","year":"2008","unstructured":"Kim EY, Moudgil KD (2008) Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol Lett 120(1\u20132):1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2008.07.008","journal-title":"Immunol Lett"},{"issue":"1","key":"1767_CR62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-immunol-101220-023458","volume":"40","author":"T Kishimoto","year":"2022","unstructured":"Kishimoto T, Kang S (2022) IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19. Annu Rev Immunol 40(1):323\u2013348","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"1767_CR63","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/1529-0131(200007)43:7<1488::AID-ANR11>3.0.CO;2-G","volume":"43","author":"MC Kraan","year":"2000","unstructured":"Kraan MC, De Koster BM, Elferink JG, Post WJ, Breedveld FC, Tak PP (2000) Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients. Arthritis Rheumatism off J Am Coll Rheumatol. 43(7):1488\u20131495","journal-title":"Arthritis Rheumatism off J Am Coll Rheumatol."},{"issue":"8","key":"1767_CR64","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1185\/030079907X223486","volume":"23","author":"W Kullich","year":"2007","unstructured":"Kullich W, Fagerer N, Schwann H (2007) Effect of the NSAID nimesulide on the radical scavenger glutathione S-transferase in patients with osteoarthritis of the knee. Curr Med Res Opin 23(8):1981\u20131986","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1767_CR65","doi-asserted-by":"publisher","first-page":"1548S","DOI":"10.1093\/jn\/138.8.1548S","volume":"138","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S (2008) The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr 138(8):1548S-S1553","journal-title":"J Nutr"},{"key":"1767_CR135","doi-asserted-by":"crossref","unstructured":"Leung YY, Hui LL, Kraus VB (2015) Colchicine\u2014update on mechanisms of action and therapeutic uses. In: Saunders WB (ed) Seminars in arthritis and rheumatism 45(3):341\u2013350","DOI":"10.1016\/j.semarthrit.2015.06.013"},{"issue":"2","key":"1767_CR66","doi-asserted-by":"publisher","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","volume":"83","author":"P Libby","year":"2006","unstructured":"Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83(2):456S-S460. https:\/\/doi.org\/10.1093\/ajcn\/83.2.456S","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1767_CR67","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135\u20131143","journal-title":"Circulation"},{"issue":"13","key":"1767_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945129","volume":"1","author":"X Liu","year":"2022","unstructured":"Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q (2022) Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol 1(13):945129","journal-title":"Front Immunol"},{"issue":"1","key":"1767_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1902\/annals.2001.6.1.1","volume":"6","author":"GD Lowe","year":"2001","unstructured":"Lowe GD (2001) The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 6(1):1\u20138. https:\/\/doi.org\/10.1902\/annals.2001.6.1.1","journal-title":"Ann Periodontol"},{"issue":"5","key":"1767_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/ptr.6338","volume":"33","author":"M Majeed","year":"2019","unstructured":"Majeed M, Majeed S, Narayanan NK, Nagabhushanam K (2019) A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res 33(5):1457\u20131468","journal-title":"Phytother Res"},{"key":"1767_CR71","doi-asserted-by":"publisher","first-page":"175394472312152","DOI":"10.1177\/17539447231215213","volume":"17","author":"AA Mangoni","year":"2023","unstructured":"Mangoni AA, Sotgia S, Zinellu A, Carru C, Pintus G, Damiani G, Erre GL, Tommasi S (2023) Methotrexate and cardiovascular prevention: an appraisal of the current evidence. Ther Adv Cardiovasc Dis 17:17539447231215212","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"2","key":"1767_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","volume":"117","author":"L Marnell","year":"2005","unstructured":"Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117(2):104\u2013111","journal-title":"Clin Immunol"},{"issue":"5","key":"1767_CR73","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/ATVBAHA.110.213850","volume":"31","author":"BH Maskrey","year":"2011","unstructured":"Maskrey BH, Megson IL, Whitfield PD, Rossi AG (2011) Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol 31(5):1001\u20131006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20133","key":"1767_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","volume":"42","author":"C Mold","year":"1999","unstructured":"Mold C, Gewurz H, Du Clos TW (1999) Regulation of complement activation by C-reactive protein. Immunopharmacology 42(1\u20133):23\u201330","journal-title":"Immunopharmacology"},{"issue":"4","key":"1767_CR75","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40264-019-00900-8","volume":"43","author":"N Moore","year":"2020","unstructured":"Moore N (2020) Coronary risks associated with diclofenac and other NSAIDs: an update. Drug Saf 43(4):301\u2013318","journal-title":"Drug Saf"},{"issue":"3","key":"1767_CR76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.37349\/ec.2024.00026","volume":"2","author":"F Morgado","year":"2024","unstructured":"Morgado F, Valado A, Metello J, Pereira L (2024) Laboratory markers of metabolic syndrome. Explor Cardiol 2(3):114\u20133347","journal-title":"Explor Cardiol"},{"issue":"5","key":"1767_CR77","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/life13051120","volume":"13","author":"M Musa","year":"2023","unstructured":"Musa M, Zeppieri M, Atuanya GN, Enaholo ES, Topah EK, Ojo OM, Salati C (2023) Nutritional factors: benefits in glaucoma and ophthalmologic pathologies. Life 13(5):1120","journal-title":"Life"},{"issue":"4","key":"1767_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003330","volume":"9","author":"AA Negash","year":"2013","unstructured":"Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, Jo J, Bertoletti A, Hagedorn CH, Gale M Jr (2013) IL-1\u03b2 production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 9(4):e1003330","journal-title":"PLoS Pathog"},{"issue":"3","key":"1767_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/annrheumdis-2017-212457","volume":"77","author":"E Nikiphorou","year":"2018","unstructured":"Nikiphorou E, van der Heijde D, Norton S, Landew\u00e9 RB, Molto A, Dougados M, Van den Bosch FE, Ramiro S (2018) Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study. Ann Rheum Dis 77(3):405\u2013411","journal-title":"Ann Rheum Dis"},{"key":"1767_CR80","first-page":"21","volume":"18","author":"W Nunomura","year":"1992","unstructured":"Nunomura W (1992) C-reactive protein (CRP) in animals: its chemical properties and biological functions. In Vitro 18:21","journal-title":"In Vitro"},{"issue":"9","key":"1767_CR81","first-page":"4965","volume":"8","author":"C Nuriah","year":"2024","unstructured":"Nuriah C, Iswanti FC, Pradipta A (2024) The role of high sensitivity C-reactive protein as an inflammation predictor in cardiovascular diseases. Bioscientia Med J Biomed Transl Res 8(9):4965\u20134976","journal-title":"Bioscientia Med J Biomed Transl Res"},{"issue":"2","key":"1767_CR82","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0021-9258(17)37943-7","volume":"254","author":"EB Oliveira","year":"1979","unstructured":"Oliveira EB, Gotschlich C, Liu TY (1979) Primary structure of human C-reactive protein. J Biol Chem 254(2):489\u2013502","journal-title":"J Biol Chem"},{"issue":"5","key":"1767_CR83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1570161117666190426164306","volume":"18","author":"C Papagoras","year":"2020","unstructured":"Papagoras C, Voulgari PV, Drosos AA (2020) Cardiovascular disease in spondyloarthritides. Curr Vasc Pharmacol 18(5):473\u2013487","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"1767_CR84","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10790268.2020.1773029","volume":"45","author":"A Park","year":"2022","unstructured":"Park A, Anderson D, Battaglino RA, Nguyen N, Morse LR (2022) Ibuprofen use is associated with reduced C-reactive protein and interleukin-6 levels in chronic spinal cord injury. J Spinal Cord Med 45(1):117\u2013125","journal-title":"J Spinal Cord Med"},{"issue":"8","key":"1767_CR85","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.bmc.2016.03.024","volume":"24","author":"N Paulino","year":"2016","unstructured":"Paulino N, Paulino AS, Diniz SN, de Mendon\u00e7a S, Gon\u00e7alves ID, Flores FF, Santos RP, Rodrigues C, Pardi PC, Suarez JA (2016) Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways. Bioorg Med Chem 24(8):1927\u20131935","journal-title":"Bioorg Med Chem"},{"key":"1767_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00392-019-01511-0","volume":"109","author":"A Peikert","year":"2020","unstructured":"Peikert A, Kaier K, Merz J, Manhart L, Sch\u00e4fer I, Hilgendorf I, Hehn P, Wolf D, Willecke F, Sheng X, Clemens A (2020) Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Clin Res Cardiol 109:315\u2013323","journal-title":"Clin Res Cardiol"},{"issue":"13","key":"1767_CR87","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.3390\/jcm10132835","volume":"10","author":"AM Pello Lazaro","year":"2021","unstructured":"Pello Lazaro AM, Blanco-Colio LM, Franco Pelaez JA, Tunon J (2021) Anti-Inflammatory drugs in patients with ischemic heart disease. J Clin Med 10(13):2835","journal-title":"J Clin Med"},{"issue":"12","key":"1767_CR88","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111(12):1805\u20131812","journal-title":"J Clin Investig"},{"issue":"1","key":"1767_CR89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/0961203396005001051","volume":"5","author":"M Petri","year":"1996","unstructured":"Petri M (1996) Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5(1):16\u201322","journal-title":"Lupus"},{"issue":"4","key":"1767_CR90","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1756-185X.2012.01769.x","volume":"15","author":"C Pongparadee","year":"2012","unstructured":"Pongparadee C, Penserga E, Lee DJ, Chen SL, Gill RS, Hamid A, Kumthornthip W, Liu Y, Meliala L, Misbach HJ, Tan KH (2012) Current considerations for the management of musculoskeletal pain in A sian countries: a special focus on cyclooxygenase-2 inhibitors and non-steroid anti-inflammation drugs. Int J Rheum Dis 15(4):341\u2013347","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1767_CR91","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2021","unstructured":"Pope JE, Choy EH (2021) C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. InSeminars Arthritis Rheumatism 51(1):219\u2013229","journal-title":"InSeminars Arthritis Rheumatism"},{"issue":"6","key":"1767_CR92","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1185\/030079906X104849","volume":"22","author":"KD Rainsford","year":"2006","unstructured":"Rainsford KD, Consensus Report Group on Nimesulide (2006) Nimesulide\u2013a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 22(6):1161\u201370","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"1767_CR93","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/life11101042","volume":"11","author":"E Rezu\u0219","year":"2021","unstructured":"Rezu\u0219 E, Macovei LA, Burlui AM, Cardoneanu A, Rezu\u0219 C (2021) Ischemic heart disease and rheumatoid arthritis\u2014two conditions, the same background. Life 11(10):1042","journal-title":"Life"},{"issue":"3","key":"1767_CR94","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363\u2013369","journal-title":"Circulation"},{"issue":"2","key":"1767_CR95","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1373\/clinchem.2008.119214","volume":"55","author":"PM Ridker","year":"2009","unstructured":"Ridker PM (2009) C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 55(2):209\u2013215","journal-title":"Clin Chem"},{"issue":"6","key":"1767_CR96","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/ard.2006.067777","volume":"66","author":"G Ruiz-Irastorza","year":"2007","unstructured":"Ruiz-Irastorza G, Ugarte A, Egurbide MV, Garmendia M, Pijoan JI, Martinez-Berriotxoa A, Aguirre C (2007) Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Ann Rheum Dis 66(6):815\u2013817","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1767_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4236\/ajps.2021.123030","volume":"12","author":"JP Sahoo","year":"2021","unstructured":"Sahoo JP, Behera L, Praveena J, Sawant S, Mishra A, Sharma SS, Ghosh L, Mishra AP, Sahoo AR, Pradhan P, Sahu S (2021) The golden spice turmeric (Curcuma longa) and its feasible benefits in prospering human health\u2014a review. Am J Plant Sci 12(3):455\u2013475","journal-title":"Am J Plant Sci"},{"issue":"S1","key":"1767_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/clc.4960141302","volume":"14","author":"CJ Schwartz","year":"1991","unstructured":"Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM (1991) The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14(S1):1\u20136","journal-title":"Clin Cardiol"},{"issue":"1","key":"1767_CR99","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/clpt.2011.278","volume":"91","author":"DL Scott","year":"2012","unstructured":"Scott DL (2012) Biologics-based therapy for the treatment of rheumatoid arthritis. Clin Pharmacol Ther 91(1):30\u201343","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1767_CR100","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/15376516.2012.666648","volume":"22","author":"V Selvaraju","year":"2012","unstructured":"Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, Maulik G (2012) Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease\u2013an overview. Toxicol Mech Methods 22(5):330\u2013335","journal-title":"Toxicol Mech Methods"},{"issue":"9","key":"1767_CR101","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.nut.2015.02.004","volume":"31","author":"C Serban","year":"2015","unstructured":"Serban C, Sahebkar A, Antal D, Ursoniu S, Banach M (2015) Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Nutrition 31(9):1061\u20131071","journal-title":"Nutrition"},{"issue":"3","key":"1767_CR102","first-page":"255","volume":"73","author":"MZ Siddiqui","year":"2011","unstructured":"Siddiqui MZ (2011) Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci 73(3):255","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"1767_CR103","doi-asserted-by":"publisher","first-page":"44","DOI":"10.15562\/bmj.v6i1.299","volume":"6","author":"DA Sindhughosa","year":"2017","unstructured":"Sindhughosa DA, Pranamartha AG (2017) The involvement of proinflammatory cytokines in diabetic nephropathy: focus on interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-\u00ce\u00b1) signaling mechanism. Bali Med J 6(1):44\u201351","journal-title":"Bali Med J"},{"issue":"10","key":"1767_CR104","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3389\/fimmu.2019.01655","volume":"16","author":"SK Singh","year":"2019","unstructured":"Singh SK, Agrawal A (2019) Functionality of C-reactive protein for atheroprotection. Front Immunol 16(10):1655","journal-title":"Front Immunol"},{"issue":"1","key":"1767_CR105","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1750-3639.2008.00256.x","volume":"20","author":"M Slevin","year":"2010","unstructured":"Slevin M, Matou-Nasri S, Turu M, Luque A, Rovira N, Badimon L, Boluda S, Potempa L, Sanfeliu C, De Vera N, Krupinski J (2010) Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol 20(1):151\u2013165","journal-title":"Brain Pathol"},{"issue":"4","key":"1767_CR106","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamacardio.2023.5605","volume":"9","author":"AM Small","year":"2024","unstructured":"Small AM, Pournamdari A, Melloni GE, Scirica BM, Bhatt DL, Raz I, Braunwald E, Giugliano RP, Sabatine MS, Peloso GM, Marston NA (2024) Lipoprotein (a), C-reactive protein, and cardiovascular risk in primary and secondary prevention populations. JAMA Cardiol 9(4):385\u2013391. https:\/\/doi.org\/10.1001\/jamacardio.2023.5605","journal-title":"JAMA Cardiol"},{"issue":"6","key":"1767_CR107","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014415","volume":"9","author":"MD Solomon","year":"2020","unstructured":"Solomon MD, Leong TK, Levin E, Rana JS, Jaffe MG, Sidney S, Sung SH, Lee C, DeMaria A, Go AS (2020) Cumulative adherence to secondary prevention guidelines and mortality after acute myocardial infarction. J Am Heart Assoc 9(6):e014415","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1767_CR108","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.3402\/fnr.v55i0.8326","volume":"55","author":"T Sone","year":"2011","unstructured":"Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I (2011) Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 55(1):8326","journal-title":"Food Nutr Res"},{"key":"1767_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00754","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00754","journal-title":"Front Immunol"},{"issue":"3","key":"1767_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2023.102573","volume":"35","author":"D Stojanov","year":"2023","unstructured":"Stojanov D, Lazarova E, Veljkova E, Rubartelli P, Giacomini M (2023) Predicting the outcome of heart failure against chronic-ischemic heart disease in elderly population\u2013Machine learning approach based on logistic regression, case to Villa Scassi hospital Genoa, Italy. J King Saud Univ Sci 35(3):102573","journal-title":"J King Saud Univ Sci"},{"issue":"3","key":"1767_CR111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1537-1891(02)00294-X","volume":"39","author":"AJ Szalai","year":"2002","unstructured":"Szalai AJ (2002) The biological functions of C-reactive protein. Vascul Pharmacol 39(3):105\u2013107","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"1767_CR112","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Luo Y, O\u2019Shea JJ, Nakayamada S (2022) Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat Rev Rheumatol 18(3):133\u2013145","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1767_CR113","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1002\/art.34644","volume":"64","author":"S Tarp","year":"2012","unstructured":"Tarp S, Bartels EM, Bliddal H, Furst DE, Boers M, Danneskiold-Sams\u00f8e B, Rasmussen M, Christensen R (2012) Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum 64(11):3511\u20133521","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1767_CR114","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/bioo.2001.1208","volume":"29","author":"E Tjendraputra","year":"2001","unstructured":"Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC (2001) Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 29(3):156\u2013163","journal-title":"Bioorg Chem"},{"issue":"4","key":"1767_CR115","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12013-022-01089-x","volume":"80","author":"N Ullah","year":"2022","unstructured":"Ullah N, Wu Y (2022) Regulation of conformational changes in C-reactive protein alters its bioactivity. Cell Biochem Biophys 80(4):595\u2013608","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"1767_CR116","first-page":"1000019","volume":"2","author":"A Urman","year":"2018","unstructured":"Urman A, Taklalsingh N, Sorrento C, McFarlane IM (2018) Inflammation beyond the joints: rheumatoid arthritis and cardiovascular disease. Scifed J Cardiol 2(3):1000019","journal-title":"Scifed J Cardiol"},{"key":"1767_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2045","volume":"8","author":"VP van Halm","year":"2006","unstructured":"van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:1\u20136","journal-title":"Arthritis Res Ther"},{"issue":"sup102","key":"1767_CR118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/03009749609097226","volume":"25","author":"JR Vane","year":"1996","unstructured":"Vane JR, Botting RM (1996) Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 25(sup102):9\u201321","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"1767_CR119","first-page":"301","volume":"37","author":"S Venuturupalli","year":"2017","unstructured":"Venuturupalli S (2017) Immune mechanisms and novel targets in rheumatoid arthritis. Immunol Allergy Clin 37(2):301\u2013313","journal-title":"Immunol Allergy Clin"},{"key":"1767_CR120","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2147\/JMDH.S285469","volume":"12","author":"AK Verma","year":"2021","unstructured":"Verma AK, Bhatt D, Goyal Y, Dev K, Beg MM, Alsahli MA, Rahmani AH (2021) Association of rheumatoid arthritis with diabetic comorbidity: correlating accelerated insulin resistance to inflammatory responses in patients. J Multidiscip Healthc 12:809\u2013820","journal-title":"J Multidiscip Healthc"},{"issue":"2","key":"1767_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/20571","volume":"11","author":"K Vohra","year":"2015","unstructured":"Vohra K, Krishan P, Varma S, Kalra HS (2015) Sulfasalazine improves insulin resistance and endothelial dysfunction in metabolic syndrome patients. Br J Med Med Res 11(2):1\u20139","journal-title":"Br J Med Med Res"},{"issue":"9","key":"1767_CR122","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","volume":"8","author":"DJ Wallace","year":"2012","unstructured":"Wallace DJ, Gudsoorkar VS, Weisman MH, Venuturupalli SR (2012) New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat Rev Rheumatol 8(9):522\u2013533","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1767_CR123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0006-2952(02)01445-4","volume":"65","author":"A Wattel","year":"2003","unstructured":"Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P, Brazier M (2003) Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65(1):35\u201342","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1767_CR124","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","volume":"49","author":"SL Westlake","year":"2010","unstructured":"Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 49(2):295\u2013307","journal-title":"Rheumatology"},{"issue":"2","key":"1767_CR125","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.0004-8666.2003.00039.x","volume":"43","author":"KE Willetts","year":"2003","unstructured":"Willetts KE, Ekangaki A, Eden JA (2003) Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol 43(2):139\u2013144","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1767_CR126","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/TCRM.S198403","volume":"24","author":"W Xie","year":"2019","unstructured":"Xie W, Luo Y, Liang X, Lin Z, Wang Z, Liu M (2019) The efficacy and safety of aspirin as the primary prevention of cardiovascular disease: an updated meta-analysis. Ther Clin Risk Manag 24:1129\u20131140","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"1767_CR127","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC (2021) Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev 73(3):924\u2013967","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1767_CR128","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1248\/jhs.48.209","volume":"48","author":"M Yamaguchi","year":"2002","unstructured":"Yamaguchi M (2002) Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J Health Sci 48(3):209\u2013222","journal-title":"J Health Sci"},{"issue":"11","key":"1767_CR129","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3390\/jcm9113469","volume":"9","author":"DH Yang","year":"2020","unstructured":"Yang DH, Wang YH, Pan LF, Wei JC (2020) Cardiovascular protection of hydroxychloroquine in patients with Sj\u00f6gren\u2019s syndrome. J Clin Med 9(11):3469","journal-title":"J Clin Med"},{"key":"1767_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-019-2780-5","volume":"20","author":"G Yu","year":"2020","unstructured":"Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J (2020) Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Compl Med Therap 20:1\u20136","journal-title":"BMC Compl Med Therap"},{"issue":"4","key":"1767_CR131","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1185\/030079908X273066","volume":"24","author":"J Zacher","year":"2008","unstructured":"Zacher J, Altman R, Bellamy N, Br\u00fchlmann P, Da Silva J, Huskisson E, Taylor RS (2008) Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 24(4):925\u2013950","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"1767_CR132","doi-asserted-by":"publisher","first-page":"1338535","DOI":"10.3389\/fddsv.2024.1338535","volume":"4","author":"M Zaczkiewicz","year":"2024","unstructured":"Zaczkiewicz M, Zimmermann O, Torzewski J (2024) A short review on CRP synthesis inhibition in cardiovascular disease. Front Drug Discov 4(4):1338535","journal-title":"Front Drug Discov"},{"issue":"4","key":"1767_CR133","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.0889-7204.2002.1118.x","volume":"17","author":"JS Zebrack","year":"2002","unstructured":"Zebrack JS, Anderson JL (2002) Role of inflammation in cardiovascular disease: how to use c-reactive protein in clinical practice. Prog Cardiovasc Nurs 17(4):174\u2013185","journal-title":"Prog Cardiovasc Nurs"},{"issue":"1","key":"1767_CR134","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","volume":"128","author":"S Zhao","year":"2021","unstructured":"Zhao S, Kusminski CM, Scherer PE (2021) Adiponectin, leptin and cardiovascular disorders. Circ Res 128(1):136\u2013149","journal-title":"Circ Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01767-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:02:14Z","timestamp":1750230134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01767-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01767-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}